Fluorescence in situ hybridization detection of cytogenetic abnormalities and prognosis in multiple

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：urgeboy1

【摘要】

：

【作者】

：

Xu Zhou Jie Jin Yu LIU Zheng Li Xiang Li Jin Wang

【机构】

：

Department of Hematology,Chongqing Daping Hospital 400042

【出处】

：

The 35th World Congress of the International Society of Hema

【发表日期】

：

2014年5期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Background Multiple myeloma (MM) is a plasma-cell malignancy manifested accumulation of abnormal plasma cells in the bone marrow.The purpose of this study is to evaluate the prognosis in patients with newly diagnosed MM and to find a suitable treatment strategy for patients with MM in future.

其他文献

TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLO-HSCT BY SALVAGE CHEMOTHERAPY WITH LOW-DOSE CYTARABIN

Background Recurrence is a major cause of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute leukemia,and subsequential treatment options are very limited

会议

Early molecular response is an important prognostic factor for patients with Philadelphia Positive A

Objective Imatinib combined with chemotherapy for induction and intensification therapy has be come the standard strategy for Philadelphia-positive acute lymphocytic leukemia (Ph+ALL).Anyhow,intensifi

会议

expression of leukokocyte adhesion molecule mac-1(cd11/cd18) and l-selectin(d62l) in patients with c

Objective Chronic renal failure(CRF) patients present with signs of immunodeficiency such as increased incidence of infections.Cell adhesion molecules determining leukocyte migration may be responsibl

会议

Serum Hepcidin detects Iron Deficiency Anemia in patients with pulmonary tuberculosis

Objective Anemia with hypoferremia can be due to either iron deficiency or inflammation.sTfR/log ferritin index is believed to be a biochemical "gold standard" to indicate the iron stores in the body.

会议

Report of Series Data Set for 40 samples from HAPC groups-using inflammation array

Aim To analysis the diversity of inflammation agents expression in the patients of high altitude polycythemia(HAPC).Methods the serum specimen of 20 cases and 20 controls were collected.The serum spec

会议

Administration of novel agents in the frontline therapy improved overall survival of patients with m

Background Treatments for multiple myeloma (MM) have dramatically improved now.The immunomodulatory drug (IMiDs) thalidomide and proteasome inhibitor (PI) bortezomib are administrated to patients with

会议

The applicability of the International Staging System in Chinese patients with multiple myeloma rece

Objective The International Staging System (ISS) is an important prognostic indicator for outcome of patients with multiple myeloma (MM).ISS was proposed in 2005 using data from 10,750 MM patients who

会议

Bortezomib-thalidomide-based regimens improved clinical outcomes without increasing toxicity as indu

Objective Novel agents-based anti-myeloma regimens including thalidomide and bortezomib have significantly improved myeloma treatment.However,it remains unclear whether patients will benefit more from

会议

Differential gene expression profile and biological features of bone marrow mesenchymal stem cells i

Objective High altitude polycythemia (HAPC) is characterized by excessive erythrocytes and enhanced angiogenesis,which is caused by environmental factors such as hypoxia and cold at high altitude.Howe

会议

Molecular Cytogenetic Aberrations in Thai Patients with Multiple Myeloma Ramathibodi Experience

Introduction Cytogenetic abnormality plays an important role in prognosis of patients with multiple myeloma (MM).Conventional cytogenetic assay reveals limited results.In this study,we performed inter

会议

Fluorescence in situ hybridization detection of cytogenetic abnormalities and prognosis in multiple

其他学术论文